Mika Newton and Tom Neyarapally discuss how AI is changing the landscape of drug discovery. They examine the role of machine learning, patient data, and computational tools in accelerating the process, reducing costs, and improving the chances of developing effective treatments. The conversation covers how AI-driven screening, drug repurposing, and real-world data integration are helping to overcome traditional challenges in bringing new therapies to patients faster.

In this episode, Dr. Sanjay Juneja and Dr. Debra Patt discuss AI in healthcare. They cover its applications in cancer care, from improving diagnostics and treatment decisions to enhancing patient education and real-time symptom management. The conversation also highlights AI's potential in drug discovery, reducing healthcare costs, optimizing administrative workflows, and addressing the challenges of data integration and biases in AI systems.